Application of lidocaine in neonatal intubation

Evaluating application of lidocaine spray vs. Normal saline spray in preventing complications of neonatal intubation

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT201305188680N2

Enrollment

Registered

2014-02-03

Start date

2014-01-20

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

local Vagous nerve anesthesia. Disorders of vagus nerve

Interventions

Intervention 1: lidocain spray 1puff (3 mg/kg)before intubation. Intervention 2: Normal saline spray 1 puff before intervention.

Prevention

lidocain spray 1puff (3 mg/kg)before intubation

Normal saline spray 1 puff before intervention

Eligibility

Sex/Gender

All

Age

1 Years to 28 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: Neonate with GA more than 30 weeks ;without oropharyngeal anomaly and renal mass ;without congenital heart disease Exclusion criteria :Neonates before 30weeks; neonates with renal mass or oropharyngeal anomaly ;neonates with congenital heart disease

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Heart rate. Timepoint: fefor and after intervention. Method of measurement: monitor bite/min.;Blood pressure. Timepoint: befor and after intervention. Method of measurement: blood pressure monitor mmhg.;Oxygen saturation. Timepoint: befor and after intervention. Method of measurement: pulsoxymeter mmhg.	—

Secondary

Measure	Time frame
Intubation time. Timepoint: befor and after intervention. Method of measurement: cornometer secound.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr.Mussavi,MirHadi

Ilam University of Medical Sciences

drmussavihadi@yahoo.com+98 84 1222 7120

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026